Relistor Injection, Solution
Product Images NDC 65649-552

Product Visual Gallery

This gallery contains 62 technical images submitted to the FDA as part of the official labeling for Relistor (NDC 65649-552). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Salix Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemstructure (Image 02)

Chemical structure of Methylnaltrexone bromide, the active ingredient of Relistor. The diagram depicts the molecular arrangement including rings and functional groups characteristic of this compound.*

FDA Label Image

Figure1 (Figure1)

Bar chart showing patient response percentages in two clinical studies for Relistor injection at doses of 0.15 mg/kg and 0.3 mg/kg compared to placebo. Study 4 shows approximately 62% response for 0.15 mg/kg, 58% for 0.3 mg/kg, and 14% for placebo. Study 5 shows 48% response for 0.15 mg/kg dose and 16% for placebo. The chart highlights statistically significant differences versus placebo.*

FDA Label Image

Logo (Image 56)

FDA Label Image

Logo (Image 57)

FDA Label Image

Figure A (Image 03)

An instructional illustration showing a hand holding a prefilled syringe with a needle safety guard, demonstrating the proper technique for administering a subcutaneous injection of Relistor (methylnaltrexone bromide). The image highlights correct finger positioning on the syringe and activation of the needle safety mechanism.*

FDA Label Image

Figures B And C (Image 05)

FDA Label Image

Figure D (Image 06)

FDA Label Image

Figure E (Image 09)

FDA Label Image

Figure F (Image 10)

FDA Label Image

Figure G (Image 11)

FDA Label Image

Figure H (Image 12)

FDA Label Image

Figure I (Image 14)

An instructional illustration showing a hand administering a subcutaneous injection into the abdominal area, demonstrating the injection technique relevant to Relistor (methylnaltrexone bromide) subcutaneous injection, solution.*

FDA Label Image

Figure J (Image 15)

Instructional illustration labeled Figure J showing a hand holding a syringe with a needle cap, demonstrating the proper grip or handling technique for subcutaneous injection administration.*

FDA Label Image

Figure K (Image 16)

An instructional illustration labeled 'Figure K' showing a hand pinching and lifting skin on a person's abdomen, demonstrating the technique for subcutaneous injection administration.*

FDA Label Image

Logo (Image 58)

FDA Label Image

Logo (Image 59)

FDA Label Image

Figure (Image 17)

Illustration of the vial and syringe parts for Relistor (methylnaltrexone bromide) injection, solution. The diagram shows components labeled including the vial with cap and rubber stopper, and the syringe with parts such as plunger, barrel, top of the plunger, retractable needle, and needle cap.*

FDA Label Image

Figure (Image 18)

Illustration showing recommended injection sites for subcutaneous administration of Relistor (Methylnaltrexone bromide). Figure B depicts areas on the front of the body including the abdomen and upper thigh. Figure C shows the upper outer areas of the arms and the back near the shoulder blades.*

FDA Label Image

Figure (Image 19)

An instructional illustration labeled Figure D showing a hand holding a small square adhesive, presumably a patch or dressing, being applied to the abdomen area of a torso. The image depicts proper placement of the adhesive for subcutaneous injection or treatment.*

FDA Label Image

Figure (Image 20)

Relistor 12 mg/0.6 mL injection vial label for subcutaneous use. The vial shows the product name, dosage strength, and that it is an injection solution. Manufactured by Salix Pharmaceuticals, Inc.*

FDA Label Image

Figure (Image 21)

An instructional illustration labeled 'Figure F' showing a hand holding a small vial of Relistor (Methylnaltrexone bromide) injection solution, preparing for subcutaneous administration. The vial's label is partially visible.*

FDA Label Image

Figure (Image 22)

Illustration showing the preparation of a Relistor injection vial, with a gloved hand removing or placing a cap on the vial labeled Relistor.*

FDA Label Image

Figure (Image 23)

An instructional illustration labeled 'Figure H' showing a hand holding a syringe and preparing to insert a needle into a vial or stopper, demonstrating a step in the injection process.*

FDA Label Image

Figure (Image 24)

An instructional illustration showing a hand holding a syringe with the plunger being pulled back, indicating the action of drawing medication into the syringe. The image is labeled as Figure I.*

FDA Label Image

Figure (Image 25)

An instructional illustration showing a hand holding a syringe with the plunger aligned to the 0.4 mL dose mark on the syringe barrel. The image emphasizes correct dosing technique for subcutaneous injection.*

FDA Label Image

Figure (Image 26)

An instructional illustration showing a person withdrawing Relistor (Methylnaltrexone bromide) injection solution from a vial using a syringe. The vial label identifies the product as Relistor, and the syringe is marked with volume measurements.*

FDA Label Image

Figure (Image 27)

An instructional illustration labeled Figure L showing a hand holding and pressing down on the plunger of a syringe containing a solution drawn from a vial. The image demonstrates the injection preparation step for subcutaneous administration of the solution.*

FDA Label Image

Figure (Image 28)

An instructional illustration showing a hand holding a syringe with a vial on top. The image depicts the process of drawing liquid into the syringe, with a volume scale from 0.4 ml to 1.1 ml visible and an arrow indicating the plunger is being pulled back. No specific product name or strength is shown.*

FDA Label Image

Figure (Image 29)

An instructional illustration labeled Figure N showing hands preparing a prefilled syringe by drawing liquid up to a marked level, demonstrating dosage measurement for an injection. The syringe has visible volume markings from 0.5 to 1.0 mL with the liquid drawn near the 0.6 mL mark.*

FDA Label Image

Figure (Image 30)

An instructional illustration showing hands preparing a syringe with a vial, depicting the process of drawing medication from the vial into the syringe. This is related to the subcutaneous injection form of Relistor (Methylnaltrexone bromide).*

FDA Label Image

Figure (Image 31)

An instructional illustration showing a hand holding a syringe with a vial inserted at the bottom. The syringe barrel is marked with measurement graduations from 0.1 to 1.0 mL, and an arrow indicates pulling the plunger downward to draw liquid into the syringe.*

FDA Label Image

Figure (Image 32)

An instructional illustration depicting a hand administering a subcutaneous injection into the abdominal area, indicating the injection site for the medication.*

FDA Label Image

Figure (Image 55)

An instructional illustration showing a subcutaneous injection technique. It depicts a hand holding a syringe inserted at a 45-degree angle into the abdominal area, demonstrating the proper injection angle for a subcutaneous route.*

FDA Label Image

Figure (Image 33)

An illustration labeled Figure S shows a hand holding a syringe in front of an arm with the word "CLICK" displayed in a speech bubble, indicating a step in the injection process or device activation.*

FDA Label Image

Figure (Image 34)

An instructional illustration showing two syringe types labeled as Figure T and Figure U, each filled to different volume markings, likely demonstrating dosing or injection techniques for Relistor (methylnaltrexone bromide) subcutaneous injection.*

FDA Label Image

Figure (Image 35)

An instructional illustration labeled as Figure V showing a hand pinching the skin of the abdomen, which demonstrates the typical subcutaneous injection site technique for administering an injection.*

FDA Label Image

Logo (Image 60)

FDA Label Image

Logo (Image 61)

FDA Label Image

Figure (Image 36)

An instructional diagram showing the parts of a Relistor injection vial and syringe. It labels the vial's cap and rubber stopper, and the syringe components including the plunger, top of the plunger, barrel, retractable needle, and needle cap.*

FDA Label Image

Figure (Image 37)

An instructional illustration showing recommended subcutaneous injection sites. Figure B depicts front view sites including the abdomen and outer thighs, while Figure C shows back view sites on the upper arms and outer thighs. The image guides proper injection placement for medication administration.*

FDA Label Image

Figure (Image 38)

Illustration labeled 'Figure D' showing a hand applying a bandage to an area of the lower abdomen, indicating a step in the subcutaneous injection process.*

FDA Label Image

Figure (Image 39)

Relistor 12 mg/0.6 mL injection, solution vial for subcutaneous use by Salix Pharmaceuticals, Inc. The label includes the proprietary name, strength, dosage form, route, and single-dose vial indication showing clear black text on a white vial.*

FDA Label Image

Figure (Image 40)

An illustration labeled Figure F showing a hand holding a vial of Relistor injection solution, focusing on the vial's cap removal or preparation for use.*

FDA Label Image

Figure (Image 41)

An instructional illustration labeled Figure G showing fingers peeling or removing a protective seal from the top of a vial, likely as part of medication preparation steps.*

FDA Label Image

Figure (Image 42)

An instructional illustration depicting a person preparing a subcutaneous injection. One hand holds an ampule, while the other draws liquid into a syringe from the ampule, demonstrating proper technique for medication injection preparation.*

FDA Label Image

Figure (Image 43)

An instructional illustration labeled 'Figure I' depicting a person holding and preparing a syringe. The image shows one hand gripping the syringe barrel and the other hand pulling back the plunger, suggesting a step in preparing the injection solution for subcutaneous administration.*

FDA Label Image

Figure (Image 44)

An instructional diagram labeled Figure J, showing a hand holding a syringe for subcutaneous injection. The diagram highlights aligning the top of the plunger with the 0.4 mL dose mark on the syringe barrel, demonstrating proper dosing technique.*

FDA Label Image

Figure (Image 45)

An instructional diagram showing a hand holding a syringe above a vial labeled 'Relistor,' demonstrating the step of withdrawing injection solution from the vial. The syringe is marked with measurement graduations, and an arrow points downward indicating the insertion of the syringe needle into the vial for drawing the medication.*

FDA Label Image

Figure (Image 46)

An instructional illustration showing a hand holding a syringe with the plunger being pushed down, drawing liquid from a vial. The syringe barrel is marked with measurement gradations, and an arrow indicates the downward motion of the plunger, demonstrating how to withdraw medication from the vial.*

FDA Label Image

Figure (Image 47)

Illustration showing a hand holding a syringe with a vial, with a downward arrow indicating the action of pushing or drawing fluid. The syringe is marked with volume measurements from 0.4 ml to 1.0 ml. The figure is labeled as Figure M.*

FDA Label Image

Figure (Image 48)

An instructional diagram labeled 'Figure N' depicting a person using a syringe for subcutaneous injection, demonstrating how to hold and prepare the syringe for administration. The image shows detailed hand positioning during the injection process.*

FDA Label Image

Figure (Image 49)

An instructional illustration showing a person's hands holding and preparing a syringe for injection from a vial, demonstrating step-by-step subcutaneous injection technique relevant to the administration of an injectable drug like Relistor (methylnaltrexone bromide). The figure is labeled as 'Figure 0.'*

FDA Label Image

Figure (Image 50)

An instructional illustration labeled 'Figure P' showing a hand holding a vial and a syringe. The diagram depicts drawing liquid medication from the vial into the syringe by pulling the plunger downward, indicating the correct method for withdrawing the injection solution for subcutaneous administration.*

FDA Label Image

Figure (Image 51)

Illustration showing a hand gripping the abdomen, labeled as Figure Q. The image likely depicts a step or position related to the use or administration of a subcutaneous injection.*

FDA Label Image

Figure (Image 52)

Illustration showing the proper technique for subcutaneous injection at a 45-degree angle, demonstrating insertion of the needle into the abdominal area.*

FDA Label Image

Figure (Image 53)

An instructional illustration showing a person's hand holding a syringe, positioned for subcutaneous injection on the abdomen. The image likely depicts proper administration technique for Relistor (methylnaltrexone bromide) injection, solution.*

FDA Label Image

Figure (Image 54)

Illustration labeled Figure T showing a hand pinching the skin, likely demonstrating how to prepare an injection site for a subcutaneous injection.*

FDA Label Image

Logo Of Salix Pharmaceuticals Featuring The Company Name In Black Serif Font With A Circular Emblem Containing Stylized Plant Or Seed Design To The Right. The Design Emphasizes A Clean, Professional Brand Identity For A Pharmaceutical Company. (Image 01)

FDA Label Image

Logo Of Progenics Pharmaceuticals Featuring The Company Name In Black Serif Font With "progenics" In Larger Letters And "pharmaceuticals" Below In Smaller Letters. A Registered Trademark Symbol Appears At The Top Right Of "progenics." (Image 04)

FDA Label Image

Carton (Image 07)

Relistor 12 mg/0.6 mL subcutaneous injection solution carton label showing that the package contains seven pre-filled syringes with needle guard. Distributed by Salix Pharmaceuticals, Inc., the label includes usage instructions to protect the syringes from light and a note to dispense the enclosed medication guide to each patient. The active ingredient is methylnaltrexone bromide.*

FDA Label Image

Carton (Image 13)

Relistor 8 mg/0.4 mL subcutaneous injection label for pre-filled syringes containing methylnaltrexone bromide. Package includes 7 pre-filled syringes with needle guard, distributed by Salix Pharmaceuticals, Inc. The label highlights dosage strength, subcutaneous use, and storage instructions, emphasizing protection from light and single-use disposal.*

FDA Label Image

Tablet Label (Image 08)

Relistor (methylnaltrexone bromide) Tablets 150 mg label for a 90-tablet package. The label includes dosing and storage information, the NDC 65649-150-90, and states prescription use only. Distributed by Salix Pharmaceuticals, Inc., the label features a yellow background with red text specifying the area for serialization, lot, and expiration information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.